Biotech & pharma
Drug from bananas could fight Aids, hepatitis C
24 Oct 2015
A substance found in bananas and carefully edited by scientists could lead to drugs that may fight off a wide range of deadly viruses, including AIDS, hepatitis C and influenza
A biomarker for premature death
24 Oct 2015
Intimations of immortality? Gene manipulation could retard ageing
14 Oct 2015
Researchers have identified 238 genes linked to ageing, and found that switching them off extends life in yeast cells, an advance that provides new genomic targets, which could be used to boost human lifespans
Medical breakthrough as kidney grown in lab dish
08 Oct 2015
Although the kidneys cannot perform the functions of a fully formed adult kidney, the researchers hope the achievement will someday lead to new ways to treat people suffering from kidney failure
Drugs disguised as human platelets target cancer
01 Oct 2015
New test detects all viruses that infect people, animals
30 Sep 2015
The test is so sensitive that it detects variant strains of viruses that are closely related genetically
Why some smokers have healthy lungs
30 Sep 2015
Scientists customise viruses to kill bacteria
24 Sep 2015
Expert group supports human gene modification research
11 Sep 2015
A network of researchers says genetic modification of human embryos, though controversial, is essential to understand the biology of early embryos
Making nanowires from protein and DNA
09 Sep 2015
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
